SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-056467
Filing Date
2021-11-12
Accepted
2021-11-12 07:32:55
Documents
88
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q itrm-10q_20210930.htm   iXBRL 10-Q 3409583
2 EX-31.1 itrm-ex311_8.htm EX-31.1 20999
3 EX-31.2 itrm-ex312_7.htm EX-31.2 21308
4 EX-32.1 itrm-ex321_6.htm EX-32.1 10612
5 EX-32.2 itrm-ex322_9.htm EX-32.2 10604
  Complete submission text file 0001564590-21-056467.txt   13319797

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA itrm-20210930.xsd EX-101.SCH 84314
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE itrm-20210930_cal.xml EX-101.CAL 63051
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE itrm-20210930_def.xml EX-101.DEF 343503
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE itrm-20210930_lab.xml EX-101.LAB 581119
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE itrm-20210930_pre.xml EX-101.PRE 511385
11 EXTRACTED XBRL INSTANCE DOCUMENT itrm-10q_20210930_htm.xml XML 2663303
Mailing Address FITZWILLIAM COURT, 1ST FLOOR LEESON CLOSE DUBLIN 2 L2 D02 YW24
Business Address FITZWILLIAM COURT, 1ST FLOOR LEESON CLOSE DUBLIN 2 L2 D02 YW24 (872) 225-6077
Iterum Therapeutics plc (Filer) CIK: 0001659323 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38503 | Film No.: 211399598
SIC: 2834 Pharmaceutical Preparations